Review Article

BRCA Genetic Screening in Middle Eastern and North African: Mutational Spectrum and Founder BRCA1 Mutation (c.798_799delTT) in North African

Table 1

Details of studies examining BRCA1 in MENA.

StudyCase selectionRegion coveredDetection method

Hadjisavvas et al. [19]
(Cyprus)
40 familial casesAllSequencing

Loizidou et al. [20]
(Cyprus)
26 familial casesAllSequencing

Atoum and Al-Kayed [16]
(Jordan)
135 BC femalesExons 2, 11, and 20DGGE

Jalkh et al. [21]
(Lebanon)
72 familial casesAllSequencing

Ibrahim et al. [17]
(Egypt)
20 healthy females and 30 familial casesc.68_69delAG/exon 2
c.181T>G/exon5
c.5266dupC/exon 20
MS-PCR
RFLP

El-Debaky et al. [18]
(Egypt)
60 familial casesExons 2, 8, 13, and 22SSCP
Heteroduplex analysis
Sequencing

Tazzite et al. [22] 
(Morocco)
34 familial cases
6 single cases
(<40 years)
AllSequencing

Laraqui et al. [23]
(Morocco)
19 familial cases
102 early-onset sporadic (<45 years)
AllSequencing

Uhrhammer et al. [24]
(Algeria)
13 familial cases
51 young sporadic cases (<38 years)
AllSequencing
MLPA

Cherbal et al. [25]
(Algeria)
86 familial casesAllHRM
Sequencing
MLPA

Troudi et al. [26]
(Tunisia)
34 familial casesAllSequencing

Mahfoudh et al. [27]
(Tunisia)
16 familial casesAllSequencing

Riahi et al. [28]48 familial casesAllSequencing

DGGE: denaturing gradient electrophoresis; MS-PCR: mutagenically separated PCR, SSCP: single-strand conformation polymorphism, RFLP: restriction fragment length polymorphism, HRM: high-resolution melting, MLPA: multiplex ligation-dependent probe amplification.